arrow
D

Denise P. Muñoz

University of California San Francisco
H指数:13
被引数:3,747

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype

超增强子分析揭示ThPOK/ZBTB7B,一种CD4+细胞谱系决定因子,作为主调控因子限制乳腺癌细胞呈现管腔非迁移表型

2025-11-130
OAAI
Inflammation-driven Resistance to MAPK inhibition in Pediatric Gliomas: Mechanisms and Therapeutic Strategies

炎症驱动的MAPK抑制耐药性在儿童胶质瘤中的机制与治疗策略

2025-11-010
OAAI
Combinatorial targeting of avapritinib-driven MAPK activation in pediatric high-grade glioma

阿伐普利尼布诱导的MAPK激活在儿童高级别胶质瘤中的组合靶向治疗

2025-11-010
OAAI
Dynamic kinome reprogramming drives resistance to treatments in BRAFV600E pediatric gliomas, revealing actionable therapeutic vulnerabilities

动态激酶组重编程驱动BRAFV600E儿童胶质瘤对治疗的耐药性,揭示了可操作的 therapeutic vulnerabilities。

2025-11-010
OAAI
Targeting CDK1/2-driven mechanisms of resistance to BRAF and EGFR inhibition in BRAF(V600E) colorectal cancer restores therapeutic response
2024-03-220
PRE
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma
2024-02-222
OAAI
Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies
2023-11-1512
OAAI
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumors
2023-02-0918
OAAI
A protein interaction landscape of breast cancer
Science
IF45.8
2021-01-010
OA